EP2396365A4 - Polymères réductibles pour l'administration de gènes non viraux - Google Patents

Polymères réductibles pour l'administration de gènes non viraux

Info

Publication number
EP2396365A4
EP2396365A4 EP10741516.8A EP10741516A EP2396365A4 EP 2396365 A4 EP2396365 A4 EP 2396365A4 EP 10741516 A EP10741516 A EP 10741516A EP 2396365 A4 EP2396365 A4 EP 2396365A4
Authority
EP
European Patent Office
Prior art keywords
gene delivery
viral gene
reducible polymers
reducible
polymers
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP10741516.8A
Other languages
German (de)
English (en)
Other versions
EP2396365A2 (fr
Inventor
Malavosklish Bikram
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Houston
Original Assignee
University of Houston
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Houston filed Critical University of Houston
Publication of EP2396365A2 publication Critical patent/EP2396365A2/fr
Publication of EP2396365A4 publication Critical patent/EP2396365A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/7105—Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/595—Polyamides, e.g. nylon
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G69/00—Macromolecular compounds obtained by reactions forming a carboxylic amide link in the main chain of the macromolecule
    • C08G69/02—Polyamides derived from amino-carboxylic acids or from polyamines and polycarboxylic acids
    • C08G69/08—Polyamides derived from amino-carboxylic acids or from polyamines and polycarboxylic acids derived from amino-carboxylic acids
    • C08G69/10—Alpha-amino-carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G69/00—Macromolecular compounds obtained by reactions forming a carboxylic amide link in the main chain of the macromolecule
    • C08G69/48—Polymers modified by chemical after-treatment
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polyamides (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
EP10741516.8A 2009-02-11 2010-02-11 Polymères réductibles pour l'administration de gènes non viraux Withdrawn EP2396365A4 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20739209P 2009-02-11 2009-02-11
PCT/US2010/000390 WO2010093452A2 (fr) 2009-02-11 2010-02-11 Polymères réductibles pour l'administration de gènes non viraux

Publications (2)

Publication Number Publication Date
EP2396365A2 EP2396365A2 (fr) 2011-12-21
EP2396365A4 true EP2396365A4 (fr) 2013-10-30

Family

ID=42562238

Family Applications (1)

Application Number Title Priority Date Filing Date
EP10741516.8A Withdrawn EP2396365A4 (fr) 2009-02-11 2010-02-11 Polymères réductibles pour l'administration de gènes non viraux

Country Status (2)

Country Link
EP (1) EP2396365A4 (fr)
WO (1) WO2010093452A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8992991B2 (en) 2009-05-15 2015-03-31 The Johns Hopkins University Multicomponent degradable cationic polymers
WO2014204264A1 (fr) * 2013-06-21 2014-12-24 가톨릭대학교 산학협력단 Polynucléotide réducteur ou non réducteur pour l'administration de médicaments et procédé de préparation dudit nucléotide

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009061456A2 (fr) * 2007-11-07 2009-05-14 University Of Houston Nanoparticules d'oxyde de fer superparamagnétique ultra-petites et leurs utilisations

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5942253A (en) * 1995-10-12 1999-08-24 Immunex Corporation Prolonged release of GM-CSF
WO2000002950A1 (fr) * 1998-07-13 2000-01-20 Expression Genetics, Inc. Analogue polyester de poly-l-lysine utilise comme transporteur de gene soluble biodegradable

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009061456A2 (fr) * 2007-11-07 2009-05-14 University Of Houston Nanoparticules d'oxyde de fer superparamagnétique ultra-petites et leurs utilisations

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
AHN C-H ET AL: "Synthesis of biodegradable multi-block copolymers of poly(l-lysine) and poly(ethylene glycol) as a non-viral gene carrier", JOURNAL OF CONTROLLED RELEASE, ELSEVIER, AMSTERDAM, NL, vol. 97, no. 3, 7 July 2004 (2004-07-07), pages 567 - 574, XP004519519, ISSN: 0168-3659, DOI: 10.1016/J.JCONREL.2004.04.002 *
MALAVOSKLISH BIKRAM ET AL: "-lysine)- g -histidine Multiblock Copolymers for Nonviral Gene Delivery", MACROMOLECULES, vol. 37, no. 5, 1 March 2004 (2004-03-01), pages 1903 - 1916, XP055079715, ISSN: 0024-9297, DOI: 10.1021/ma035650c *
PARKER ET AL: "(LYS)16-based reducible polycations provide stable polyplexes with anionic fusogenic peptides and efficient gene delivery to post mitotic cells", BIOCHIMICA ET BIOPHYSICA ACTA (BBA) - GENERAL SUBJECTS, ELSEVIER, vol. 1770, no. 9, 16 August 2007 (2007-08-16), pages 1331 - 1337, XP022201959, ISSN: 0304-4165, DOI: 10.1016/J.BBAGEN.2007.06.009 *
READ M L ET AL: "A versatile reducible polycation-based system for efficient delivery of a broad range of nucleic acids", NUCLEIC ACIDS RESEARCH, INFORMATION RETRIEVAL LTD, vol. 33, no. 9, 1 May 2005 (2005-05-01), pages e86 - 1, XP002447464, ISSN: 0305-1048, [retrieved on 20050524], DOI: 10.1093/NAR/GNI085 *
READ M L ET AL: "Vectors based on reducible polycations facilitate intracellular release of nucleic acids", JOURNAL OF GENE MEDICINE, JOHN WILEY & SONS, INC, US, vol. 5, no. 3, 1 March 2003 (2003-03-01), pages 232 - 245, XP002481542, ISSN: 1099-498X, DOI: 10.1002/JGM.331 *

Also Published As

Publication number Publication date
WO2010093452A3 (fr) 2010-11-25
EP2396365A2 (fr) 2011-12-21
WO2010093452A2 (fr) 2010-08-19

Similar Documents

Publication Publication Date Title
EP2496268A4 (fr) Systèmes de délivrance de gènes à base de nanoparticules
EP2401012A4 (fr) Système de distribution de médicaments
HUE059078T2 (hu) Glutation-alapú hatóanyagszállító rendszer
GB0903810D0 (en) Delivery system
EP2409240A4 (fr) Système de délivrance de média à débit variable
EP2635974A4 (fr) Distribution de données
ZA201106060B (en) Automated oxygen delivery system
IL215608A0 (en) Drug delivery composition
EP2523606C0 (fr) Système de distribution transcorporelle
EP2481399A4 (fr) Système d administration de médicament à libération prolongée
GB0909319D0 (en) Transluminal delivery system
IL207975A0 (en) Polymer derived from linear polyethylenimine for gene transfer
GB0902014D0 (en) SMS delivery technique
EP2416965A4 (fr) Système de délivrance d'encre
EP2498698A4 (fr) Systèmes et procédés de distribution de matériau durcissable
GB0904957D0 (en) Tumour gene profile
PL2437736T3 (pl) Systemy dostarczania leków
GB201006818D0 (en) Drug delivery
EP2396365A4 (fr) Polymères réductibles pour l'administration de gènes non viraux
GB2480144B (en) High flow ink delivery system
GB201203645D0 (en) Fluid delivery system
EP2616813A4 (fr) Biocapteurs génétiques hébergés par l'hôte
GB0917792D0 (en) Delivery agent
GB0817486D0 (en) Delivery system
GB0914524D0 (en) Delivery method

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20110908

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20130926

RIC1 Information provided on ipc code assigned before grant

Ipc: C08G 69/48 20060101AFI20130920BHEP

Ipc: A61K 48/00 20060101ALI20130920BHEP

Ipc: C08G 69/10 20060101ALI20130920BHEP

Ipc: A61K 9/16 20060101ALI20130920BHEP

Ipc: A61K 47/34 20060101ALI20130920BHEP

Ipc: C12N 15/87 20060101ALI20130920BHEP

Ipc: A61K 31/7105 20060101ALI20130920BHEP

Ipc: A61K 47/48 20060101ALI20130920BHEP

Ipc: C08L 101/16 20060101ALI20130920BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20140426